GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » Cyclically Adjusted Price-to-FCF

Sagittarius Life Science (ROCO:3205) Cyclically Adjusted Price-to-FCF : 47.07 (As of Jun. 05, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Sagittarius Life Science Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Sagittarius Life Science's current share price is NT$43.30. Sagittarius Life Science's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was NT$0.92. Sagittarius Life Science's Cyclically Adjusted Price-to-FCF for today is 47.07.

The historical rank and industry rank for Sagittarius Life Science's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ROCO:3205' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 22.07   Med: 48.32   Max: 133.95
Current: 49.67

During the past years, Sagittarius Life Science's highest Cyclically Adjusted Price-to-FCF was 133.95. The lowest was 22.07. And the median was 48.32.

ROCO:3205's Cyclically Adjusted Price-to-FCF is ranked worse than
51.46% of 103 companies
in the Biotechnology industry
Industry Median: 49.09 vs ROCO:3205: 49.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sagittarius Life Science's adjusted free cash flow per share data for the three months ended in Mar. 2025 was NT$-0.237. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is NT$0.92 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sagittarius Life Science Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sagittarius Life Science's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagittarius Life Science Cyclically Adjusted Price-to-FCF Chart

Sagittarius Life Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.63 28.34 55.68 48.76 46.85

Sagittarius Life Science Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.90 45.44 34.75 46.85 32.30

Competitive Comparison of Sagittarius Life Science's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Sagittarius Life Science's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sagittarius Life Science's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's Cyclically Adjusted Price-to-FCF falls into.


;
;

Sagittarius Life Science Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sagittarius Life Science's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=43.30/0.92
=47.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagittarius Life Science's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sagittarius Life Science's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.237/134.9266*134.9266
=-0.237

Current CPI (Mar. 2025) = 134.9266.

Sagittarius Life Science Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.451 100.684 -0.604
201509 8.313 100.392 11.173
201512 1.542 99.792 2.085
201603 -4.847 100.470 -6.509
201606 9.997 101.688 13.265
201609 4.800 101.861 6.358
201612 1.071 101.863 1.419
201703 0.543 102.862 0.712
201706 -1.970 103.349 -2.572
201709 0.342 104.136 0.443
201712 0.267 104.011 0.346
201803 -2.072 105.290 -2.655
201806 0.316 106.317 0.401
201809 0.400 106.507 0.507
201812 -0.446 105.998 -0.568
201903 -1.179 107.251 -1.483
201906 -0.413 108.070 -0.516
201909 -0.577 108.329 -0.719
201912 -1.474 108.420 -1.834
202003 -1.451 108.902 -1.798
202006 -0.136 108.767 -0.169
202009 -0.582 109.815 -0.715
202012 -0.076 109.897 -0.093
202103 -0.956 111.754 -1.154
202106 -0.617 114.631 -0.726
202109 -0.660 115.734 -0.769
202112 1.084 117.630 1.243
202203 -1.393 121.301 -1.549
202206 -0.511 125.017 -0.552
202209 -0.690 125.227 -0.743
202212 0.945 125.222 1.018
202303 -1.805 127.348 -1.912
202306 0.067 128.729 0.070
202309 0.147 129.860 0.153
202312 -0.600 129.419 -0.626
202403 -0.584 131.776 -0.598
202406 -0.081 132.554 -0.082
202409 -0.491 133.029 -0.498
202412 -0.325 133.157 -0.329
202503 -0.237 134.927 -0.237

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sagittarius Life Science  (ROCO:3205) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sagittarius Life Science Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sagittarius Life Science's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sagittarius Life Science Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.

Sagittarius Life Science Headlines

No Headlines